Capital Research Global Investors Alnylam Pharmaceuticals, Inc. Transaction History

Capital Research Global Investors

$479 Billion
Q2 2025

A detailed history of Capital Research Global Investors transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 7,191,656 shares of ALNY stock, worth $3.09 Billion. This represents 0.49% of its overall portfolio holdings.

Number of Shares

7,191,656

Previous 7,154,728 0.52%

Holding current value

$3.09 Billion

Previous $1.93 Billion 21.39%

% of portfolio

0.49%

Previous 0.44%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$224.32 - $326.09 $8.28 Million - $12 Million	36,928 Added 0.52%	7,191,656 $2.35 Billion
Q1 2025 May 12, 2025	BUY	$233.07 - $290.7 $43.4 Million - $54.1 Million	186,215 Added 2.67%	7,154,728 $1.93 Billion
Q4 2024 Feb 13, 2025	BUY	$232.27 - $300.43 $401 Million - $518 Million	1,724,610 Added 32.89%	6,968,513 $1.64 Billion
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $465 Million - $571 Million	1,988,255 Added 61.07%	5,243,903 $1.44 Billion
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $15.9 Million - $27.3 Million	110,661 Added 3.52%	3,255,648 $791 Million
Q1 2024 May 14, 2024	BUY	$146.51 - $198.2 $31.5 Million - $42.6 Million	214,908 Added 7.33%	3,144,987 $470 Million
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $22.1 Million - $28.7 Million	146,236 Added 5.25%	2,930,079 $561 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $73.3 Million - $90.8 Million	429,082 Added 18.22%	2,783,843 $493 Million
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $15.7 Million - $18 Million	-84,835 Reduced 3.48%	2,354,761 $447 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $294 Million - $379 Million	1,607,479 Added 193.18%	2,439,596 $489 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $154 Million - $201 Million	832,117 New	832,117 $198 Million

Others Institutions Holding ALNY

# of Institutions

742

Shares Held

115M

Call Options Held

588K

Put Options Held

669K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $52.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Alnylam Pharmaceuticals, Inc. Transaction History